235 related articles for article (PubMed ID: 37187299)
1. Patient-derived extracellular matrix demonstrates role of COL3A1 in blood vessel mechanics.
Doherty EL; Aw WY; Warren EC; Hockenberry M; Whitworth CP; Krohn G; Howell S; Diekman BO; Legant WR; Nia HT; Hickey AJ; Polacheck WJ
Acta Biomater; 2023 Aug; 166():346-359. PubMed ID: 37187299
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome analysis of skin fibroblasts with dominant negative COL3A1 mutations provides molecular insights into the etiopathology of vascular Ehlers-Danlos syndrome.
Chiarelli N; Carini G; Zoppi N; Ritelli M; Colombi M
PLoS One; 2018; 13(1):e0191220. PubMed ID: 29346445
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of extracellular matrix and Lysyl Oxidase in Ehlers-Danlos syndrome type IV skin fibroblasts.
Foehr R; Anderson K; Dombrowski O; Foehr A; Foehr ED
Orphanet J Rare Dis; 2024 Jan; 19(1):9. PubMed ID: 38183136
[TBL] [Abstract][Full Text] [Related]
4. Type III collagen affects dermal and vascular collagen fibrillogenesis and tissue integrity in a mutant Col3a1 transgenic mouse model.
D'hondt S; Guillemyn B; Syx D; Symoens S; De Rycke R; Vanhoutte L; Toussaint W; Lambrecht BN; De Paepe A; Keene DR; Ishikawa Y; Bächinger HP; Janssens S; Bertrand MJM; Malfait F
Matrix Biol; 2018 Sep; 70():72-83. PubMed ID: 29551664
[TBL] [Abstract][Full Text] [Related]
5. A multi-institutional experience in the aortic and arterial pathology in individuals with genetically confirmed vascular Ehlers-Danlos syndrome.
Shalhub S; Byers PH; Hicks KL; Charlton-Ouw K; Zarkowsky D; Coleman DM; Davis FM; Regalado ES; De Caridi G; Weaver KN; Miller EM; Schermerhorn ML; Shean K; Oderich G; Ribeiro M; Nishikawa C; Behrendt CA; Debus ES; von Kodolitsch Y; Powell RJ; Pepin M; Milewicz DM; Lawrence PF; Woo K
J Vasc Surg; 2019 Nov; 70(5):1543-1554. PubMed ID: 31126764
[TBL] [Abstract][Full Text] [Related]
6. Splenic artery pathology presentation, operative interventions, and outcomes in 88 patients with vascular Ehlers-Danlos syndrome.
Shalhub S; Nkansah R; El-Ghazali A; Hillenbrand CJ; Vaidya SS; Schwarze U; Byers PH
J Vasc Surg; 2023 Aug; 78(2):394-404. PubMed ID: 37068529
[TBL] [Abstract][Full Text] [Related]
7. Genetic aspects of the vascular type of Ehlers-Danlos syndrome (vEDS, EDSIV) in Japan.
Watanabe A; Kosho T; Wada T; Sakai N; Fujimoto M; Fukushima Y; Shimada T
Circ J; 2007 Feb; 71(2):261-5. PubMed ID: 17251678
[TBL] [Abstract][Full Text] [Related]
8. Vascular Ehlers-Danlos Syndrome With a Novel Missense COL3A1 Mutation Present With Pulmonary Complications and Iliac Arterial Dissection.
Gu G; Yang H; Cui L; Fu Y; Li F; Zhou Z; Zheng Y
Vasc Endovascular Surg; 2018 Feb; 52(2):138-142. PubMed ID: 29216800
[TBL] [Abstract][Full Text] [Related]
9. Allele-specific siRNA knockdown as a personalized treatment strategy for vascular Ehlers-Danlos syndrome in human fibroblasts.
Müller GA; Hansen U; Xu Z; Griswold B; Talan MI; McDonnell NB; Briest W
FASEB J; 2012 Feb; 26(2):668-77. PubMed ID: 22038052
[TBL] [Abstract][Full Text] [Related]
10. Vascular Ehlers-Danlos syndrome with a Novel missense COL3A1 gene mutation present with bilateral spontaneous carotid-cavernous fistula: a case report.
Tatebayashi K; Shirakawa M; Abe S; Fujita M; Yoshimura S
Acta Neurochir (Wien); 2023 Dec; 165(12):3799-3804. PubMed ID: 37917379
[TBL] [Abstract][Full Text] [Related]
11. Clinical, structural, biochemical and X-ray crystallographic correlates of pathogenicity for variants in the C-propeptide region of the COL3A1 gene.
Stembridge NS; Vandersteen AM; Ghali N; Sawle P; Nesbitt M; Pollitt RC; Ferguson DJ; Holden S; Elmslie F; Henderson A; Hulmes DJ; Pope FM
Am J Med Genet A; 2015 Aug; 167A(8):1763-72. PubMed ID: 25846194
[TBL] [Abstract][Full Text] [Related]
12. Endoplasmic reticulum stress and collagenous formation anomalies in vascular-type Ehlers-Danlos syndrome via electron microscopy.
Ishikawa S; Kosho T; Kaminaga T; Miyamoto M; Hamasaki Y; Yoshihara S; Hayashi S; Igawa K
J Dermatol; 2021 Apr; 48(4):481-485. PubMed ID: 33523542
[TBL] [Abstract][Full Text] [Related]
13. Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.
Kuivaniemi H; Tromp G
Gene; 2019 Jul; 707():151-171. PubMed ID: 31075413
[TBL] [Abstract][Full Text] [Related]
14. Recurrent pneumothorax and intrapulmonary cavitary lesions in a male patient with vascular Ehlers-Danlos syndrome and a novel missense mutation in the COL3A1 gene: a case report.
Wan T; Ye J; Wu P; Cheng M; Jiang B; Wang H; Li J; Ma J; Wang L; Huang X
BMC Pulm Med; 2020 May; 20(1):149. PubMed ID: 32471395
[TBL] [Abstract][Full Text] [Related]
15. Cervical artery dissections and type A aortic dissection in a family with a novel missense COL3A1 mutation of vascular type Ehlers-Danlos syndrome.
Makrygiannis G; Loeys B; Defraigne JO; Sakalihasan N
Eur J Med Genet; 2015 Nov; 58(11):634-6. PubMed ID: 26497932
[TBL] [Abstract][Full Text] [Related]
16. Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes.
Shalhub S; Black JH; Cecchi AC; Xu Z; Griswold BF; Safi HJ; Milewicz DM; McDonnell NB
J Vasc Surg; 2014 Jul; 60(1):160-9. PubMed ID: 24650746
[TBL] [Abstract][Full Text] [Related]
17. Identification of two novel COL3A1 variants in patients with vascular Ehlers-Danlos syndrome.
Heo WY; Jang SY; Park TK; Ki CS; Kim JW; Kim DK; Jang JH
Mol Genet Genomic Med; 2023 Sep; 11(9):e2240. PubMed ID: 37461200
[TBL] [Abstract][Full Text] [Related]
18. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
Schwarze U; Schievink WI; Petty E; Jaff MR; Babovic-Vuksanovic D; Cherry KJ; Pepin M; Byers PH
Am J Hum Genet; 2001 Nov; 69(5):989-1001. PubMed ID: 11577371
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-β and inflammation in vascular (type IV) Ehlers-Danlos syndrome.
Morissette R; Schoenhoff F; Xu Z; Shilane DA; Griswold BF; Chen W; Yang J; Zhu J; Fert-Bober J; Sloper L; Lehman J; Commins N; Van Eyk JE; McDonnell NB
Circ Cardiovasc Genet; 2014 Feb; 7(1):80-8. PubMed ID: 24399159
[TBL] [Abstract][Full Text] [Related]
20. Type III and V collagens modulate the expression and assembly of EDA(+) fibronectin in the extracellular matrix of defective Ehlers-Danlos syndrome fibroblasts.
Zoppi N; Ritelli M; Colombi M
Biochim Biophys Acta; 2012 Oct; 1820(10):1576-87. PubMed ID: 22705941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
